pharma news

News

MSD, Eisai abandon combination trial in liver cancer

MSD and Eisai's oncology partnership has had mixed fortunes this week, with a disappointment in liver cancer and encouraging data in kidney cancer.

News

BridgeBio two for two as rare disease drug aces ph3 trial

BridgeBio's week just went from great to superb, as it reports a second positive topline result in a pivotal trial of a late-stage pipeline drug.

News

Specialty meds lift GSK's outlook in Walmsley's swan song

Emma Walmsley's last set of financial results as GSK's chief executive has gone swimmingly, allowing the company to raise its 2025 forecasts.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Lilly partners NVIDIA to build 'most powerful' supercomputer

Eli Lilly and NVIDIA have joined forces on an ambitious plan – building pharma's most powerful AI-powered supercomputer for drug discovery.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

MSD, Eisai abandon combination trial in liver cancer

BridgeBio two for two as rare disease drug aces ph3 trial

Specialty meds lift GSK's outlook in Walmsley's swan song

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Lilly partners NVIDIA to build 'most powerful' supercomputer

Texas sues J&J, Kenvue over Tylenol autism claim

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks